Australia Drug Delivery Devices Market Trends By Type Of Product, Application Area And End-User - Forecast To 2035

(MENAFN- GlobeNewsWire - Nasdaq) Australia's drug delivery devices market sees growth opportunities in addressing chronic illnesses with innovations like smart auto-injectors, AI wearables, and microneedle patches

Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The "Australia Drug Delivery Devices Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Product, Application Area and End-user" has been added to ResearchAndMarkets's offering.

The Australia drug delivery devices market is set for remarkable growth, expanding from USD 3.46 billion in the current year to USD 11.25 billion by 2035, reflecting a CAGR of 14% over the forecast period.

Drug delivery devices are essential for managing conditions such as asthma, COPD, diabetes, cancer, cardiovascular diseases, and chronic pain. The market is witnessing significant advancements focusing on smart connectivity and precision dosing through technologies like nanotechnology and targeted release. The increase in chronic illnesses among an aging population is a major growth accelerator, highlighting the need for innovative devices like injectables, inhalers, and auto-injectors. Technology innovations, including AI-driven wearable pumps and needle-free systems, further enhance patient adherence and support Australia's digital health initiatives.

Growth Drivers

The market is propelled by the increasing prevalence of chronic diseases and the need for effective delivery systems such as auto-injectors and implants. Advances in connected devices and pre-filled syringes are boosting adherence while aligning with Australia's healthcare ecosystem. Government investments in healthcare infrastructure and telemedicine policies further accelerate market growth.

Market Challenges

Despite growth drivers, challenges such as strict TGA regulations and high development costs pose hurdles. Approval processes may hinder innovators, and reimbursement issues affect market penetration. Competition from major players and low awareness about device benefits also dampen adoption. Supply chain issues and manufacturing complexities add risks in this competitive sector.

Key Segments

Type of Product:

• Inhalers
• Injection Devices
• Transdermal Patches

Application Area:

• Oncology
• Infectious Diseases
• Respiratory Diseases
• Diabetes

End User:

• Hospitals
• Diagnostic Centers
• Home Care Settings
• Others

Key Questions Answered:

• How many drug delivery device developers in Australia are currently engaged in this market?
• Which are the leading companies in this market?
• Which country dominates the Australia drug delivery devices market?
• What are the key trends observed in the Australia drug delivery devices market?
• What factors are likely to influence the evolution of this market?
• What are the primary challenges faced by the Australia drug delivery devices market?
• What is the current and future Australia drug delivery devices market size?
• What is the CAGR of the Australia drug delivery devices market?
• How is the current and future market opportunity likely to be distributed across key market segments?

Reasons to Buy this Report:

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
• The report can aid businesses in identifying future opportunities in any sector. It also helps in understanding if those opportunities are worth pursuing.
• The report helps in identifying customer demand by understanding the needs, preferences, and behavior of the target audience in order to tailor products or services effectively.
• The report equips new entrants with requisite information regarding a particular market to help them build successful business strategies.
• The report allows for more effective communication with the audience and in building strong business relations.

A selection of companies mentioned in this report includes, but is not limited to:

• AbbVie
• Bayer
• Becton Dickinson and Company
• GlaxoSmithKline
• Johnson & Johnson
• Novartis
• Novo Nordisk
• Pfizer
• Sanofi
• SiBiono GeneTech
• Teva Pharmaceutical Industries
• Viatris

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN07042026004107003653ID1110953079